Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_provenance.
- NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_provenance.
- NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_assertion evidence source_evidence_literature NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_provenance.
- NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_assertion SIO_000772 23441129 NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_provenance.
- NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_assertion wasDerivedFrom befree-20150227 NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_provenance.
- NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_assertion wasGeneratedBy ECO_0000203 NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP369427.RAs2lk8cmU8vXgSeiTmSJ8M2tu_HX04iUr9idPfV3CVK0130_provenance.